Found: 60
Select item for more details and to access through your institution.
Potential efficacy of therapies targeting intrahepatic lesions after sorafenib treatment of patients with hepatocellular carcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Peptide vaccine-treated, long-term surviving cancer patients harbor self-renewing tumor-specific CD8<sup>+</sup> T cells.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30861-z
- By:
- Publication type:
- Article
Plasma Antithrombin III Levels Can Be a Prognostic Factor in Liver Cirrhosis Patients with Portal Vein Thrombosis.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 9, p. 7732, doi. 10.3390/ijms24097732
- By:
- Publication type:
- Article
Alterations in Hepatocellular Carcinoma-Specific Immune Responses Following Hepatitis C Virus Elimination by Direct-Acting Antivirals.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11623, doi. 10.3390/ijms231911623
- By:
- Publication type:
- Article
FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 15, p. 8305, doi. 10.3390/ijms23158305
- By:
- Publication type:
- Article
Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Expression of chondroitin-glucuronate C5-epimerase and cellular immune responses in patients with hepatocellular carcinoma.
- Published in:
- Liver International, 2012, v. 32, n. 10, p. 1516, doi. 10.1111/j.1478-3231.2012.02853.x
- By:
- Publication type:
- Article
dUTP pyrophosphatase expression correlates with a poor prognosis in hepatocellular carcinoma.
- Published in:
- Liver International, 2010, v. 30, n. 3, p. 438, doi. 10.1111/j.1478-3231.2009.02177.x
- By:
- Publication type:
- Article
The development and clinical features of splenic aneurysm associated with liver cirrhosis.
- Published in:
- Liver International, 2006, v. 26, n. 3, p. 291, doi. 10.1111/j.1478-3231.2005.01231.x
- By:
- Publication type:
- Article
Efficacy of a novel self-expandable metal stent with dumbbell-shaped flare ends for distal biliary obstruction due to unresectable pancreatic cancer.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-25186-2
- By:
- Publication type:
- Article
Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis.
- Published in:
- Life (2075-1729), 2020, v. 10, n. 9, p. 177, doi. 10.3390/life10090177
- By:
- Publication type:
- Article
Programmed cell death-1 is involved with peripheral blood immune cell profiles in patients with hepatitis C virus antiviral therapy.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0299424
- By:
- Publication type:
- Article
Post-allogeneic Hematopoietic Stem Cell Transplantation Portal Hypertension Not Associated with Liver Cirrhosis, Veno-occlusive Disease, or Graft-versus-host Disease.
- Published in:
- Internal Medicine, 2024, v. 63, n. 11, p. 1563, doi. 10.2169/internalmedicine.2489-23
- By:
- Publication type:
- Article
The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial.
- Published in:
- Diabetologia, 2014, v. 57, n. 5, p. 878, doi. 10.1007/s00125-013-3149-9
- By:
- Publication type:
- Article
Successful second‐line treatment with cabozantinib for hepatocellular carcinoma harboring cytoplasmic mesenchymal–epithelial transition factor amplification.
- Published in:
- Hepatology Research, 2024, v. 54, n. 3, p. 315, doi. 10.1111/hepr.13975
- By:
- Publication type:
- Article
Safety and efficacy of sorafenib followed by regorafenib or lenvatinib in patients with hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2021, v. 51, n. 2, p. 190, doi. 10.1111/hepr.13588
- By:
- Publication type:
- Article
Comparative analysis of liver functional reserve during lenvatinib and sorafenib for advanced hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2020, v. 50, n. 7, p. 871, doi. 10.1111/hepr.13505
- By:
- Publication type:
- Article
Analysis of the liver functional reserve of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: Prospects for regorafenib therapy.
- Published in:
- Hepatology Research, 2018, v. 48, n. 12, p. 956, doi. 10.1111/hepr.13196
- By:
- Publication type:
- Article
Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib.
- Published in:
- Hepatology Research, 2016, v. 46, n. 7, p. 650, doi. 10.1111/hepr.12601
- By:
- Publication type:
- Article
Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy.
- Published in:
- Hepatology Research, 2015, v. 45, n. 9, p. 949, doi. 10.1111/hepr.12436
- By:
- Publication type:
- Article
Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis.
- Published in:
- Hepatology Research, 2015, v. 45, n. 8, p. 846, doi. 10.1111/hepr.12423
- By:
- Publication type:
- Article
Feasibility and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma after sorafenib.
- Published in:
- Hepatology Research, 2014, v. 44, n. 12, p. 1179, doi. 10.1111/hepr.12266
- By:
- Publication type:
- Article
Virological effects and safety of combined double filtration plasmapheresis (DFPP) and interferon therapy in patients with chronic hepatitis C: A preliminary study
- Published in:
- Hepatology Research, 2006, v. 36, n. 3, p. 167, doi. 10.1016/j.hepres.2006.07.013
- By:
- Publication type:
- Article
Hepatitis B Virus (HBV) Core-Related Antigen During Nucleos(t)ide Analog Therapy Is Related to Intra-hepatic HBV Replication and Development of Hepatocellular Carcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 6, p. 715, doi. 10.1007/s00262-016-1837-2
- By:
- Publication type:
- Article
P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 5, p. 479, doi. 10.1007/s00262-014-1529-8
- By:
- Publication type:
- Article
Increase in CD14HLA-DR myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 8, p. 1421, doi. 10.1007/s00262-013-1447-1
- By:
- Publication type:
- Article
Identification of serum anti-human telomerase reverse transcriptase (hTERT) auto-antibodies during progression to hepatocellular carcinoma.
- Published in:
- Oncogene, 2002, v. 21, n. 38, p. 5946, doi. 10.1038/sj.onc.1205788
- By:
- Publication type:
- Article
Immune responses against tumour‐associated antigen‐derived cytotoxic T lymphocyte epitopes in cholangiocarcinoma patients.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 2040, doi. 10.1111/liv.13885
- By:
- Publication type:
- Article
Immune response to human telomerase reverse transcriptase‐derived helper T cell epitopes in hepatocellular carcinoma patients.
- Published in:
- Liver International, 2018, v. 38, n. 9, p. 1635, doi. 10.1111/liv.13713
- By:
- Publication type:
- Article
Response to Importance of confounding factors in assessing fatty acid compositions in patients with non-alcoholic steatohepatitis.
- Published in:
- Liver International, 2015, v. 35, n. 6, p. 1773, doi. 10.1111/liv.12755
- By:
- Publication type:
- Article
Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis.
- Published in:
- Liver International, 2015, v. 35, n. 2, p. 582, doi. 10.1111/liv.12685
- By:
- Publication type:
- Article
A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 4, p. 723, doi. 10.1007/s10637-014-0077-6
- By:
- Publication type:
- Article
Direct-Acting Antiviral Agents Reduce the Risk of Malignant Transformation of Hepatobiliary Phase-Hypointense Nodule without Arterial Phase Hyperenhancement to Hepatocellular Carcinoma on Gd-EOB-DPTAEnhanced Imaging in the Hepatitis C Virus-Infected Liver
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 3, p. 261, doi. 10.1159/000504889
- By:
- Publication type:
- Article
Management of biliary stricture in patients with IgG4-related sclerosing cholangitis.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0232089
- By:
- Publication type:
- Article
Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 10, p. 2701, doi. 10.1002/ijc.32339
- By:
- Publication type:
- Article
Identification of a secretory protein c19orf10 activated in hepatocellular carcinoma.
- Published in:
- International Journal of Cancer, 2011, v. 129, n. 7, p. 1576, doi. 10.1002/ijc.25830
- By:
- Publication type:
- Article
Enhancement of tumor-specific T-cell responses by transcatheter arterial embolization with dendritic cell infusion for hepatocellular carcinoma.
- Published in:
- International Journal of Cancer, 2010, v. 126, n. 9, p. 2164, doi. 10.1002/ijc.24882
- By:
- Publication type:
- Article
Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0170291
- By:
- Publication type:
- Article
Fatty acid-driven modifications in T-cell profiles in non-alcoholic fatty liver disease patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Serum aldo–keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis.
- Published in:
- Journal of Gastroenterology, 2019, v. 54, n. 6, p. 549, doi. 10.1007/s00535-019-01551-3
- By:
- Publication type:
- Article
Serum aldo-keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts hepatocellular carcinoma incidence and recurrence in nucleos(t)ide analogue therapy for chronic hepatitis B.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Study Protocol for Pleiotropic Effects and Safety of Sodium–Glucose Cotransporter 2 Inhibitor Versus Sulfonylurea in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 2, p. 549, doi. 10.1007/s13300-020-00762-9
- By:
- Publication type:
- Article
Randomized, Phase II Study Comparing Interferon Combined with Hepatic Arterial Infusion of Fluorouracil plus Cisplatin and Fluorouracil Alone in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Oncology, 2011, v. 81, n. 5/6, p. 281, doi. 10.1159/000334439
- By:
- Publication type:
- Article
Immune responses of human T lymphocytes to novel hepatitis B virus-derived peptides.
- Published in:
- PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0198264
- By:
- Publication type:
- Article
Upregulation of the Long Noncoding RNA HULC by Hepatitis C Virus and Its Regulation of Viral Replication.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Histological course of nonalcoholic fatty liver disease in Japanese patients: tight glycemic control, rather than weight reduction, ameliorates liver fibrosis.
- Published in:
- 2010
- By:
- Publication type:
- journal article